Multimodality treatment of metastatic renal cell carcinoma

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Expert Review of Anticancer Therapy

• Publication date

  2002-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1586/14737140.2.6.681PMID 12503214
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Principles of nephrectomy for malignant disease

  2002cited by this paper
• Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma.

  2002cited by this paper
• IL-2 in combination with IFN-αand 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial

  2001cited by this paper
• Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.

  2001cited by this paper
• Guidelines on Renal Cell Cancer

  2001cited by this paper
• Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.

  2001cited by this paper
• Effect of cytokine therapy on survival for patients with advanced renal cell carcinoma.

  2000cited by this paper
• Surgical Approaches to Organ-Confined Renal Cell Carcinoma

  2000cited by this paper
• Potential role of nephrectomy in the treatment of metastatic renal cell carcinoma: a retrospective analysis.

  2000cited by this paper
• Prognostic factors in renal cell and bladder cancer

  1999cited by this paper
• Interleukin-2 based immunotherapy for metastatic renal cell carcinoma with the kidney in place.

  1999cited by this paper
• Laparoscopic cytoreductive nephrectomy as preparation for administration of systemic interleukin-2 in the treatment of metastatic renal cell carcinoma: a pilot study.

  1999cited by this paper
• Inpatient rehabilitation helps patients with multiple sclerosis

  1999cited by this paper
• Efficacy of multimodality therapy in advanced renal cell carcinoma.

  1998cited by this paper
• Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma

  1998cited by this paper
• Resection of metastatic renal cell carcinoma.

  1998cited by this paper
• Nephrectomy before interleukin-2 therapy for patients with metastatic renal cell carcinoma.

  1997cited by this paper
• Nephrectomy for metastatic renal cell carcinoma and surgery for distant metastases.

  1996cited by this paper
• A phase II study of interferon-alpha, interleukin-2 and 5-fluorouracil in advanced renal carcinoma: clinical data and laboratory evidence of protease activation.

  1996cited by this paper
• Immunotherapy for renal cell carcinoma: the era of interleukin-2-based treatment.

  1995cited by this paper
• Cytoreductive surgery for stage IV renal cell carcinoma.

  1995cited by this paper
• The impact of adjuvant nephrectomy on multimodality treatment of metastatic renal cell carcinoma.

  1994cited by this paper
• Cytoreductive surgery before high dose interleukin-2 based therapy in patients with metastatic renal cell carcinoma.

  1993cited by this paper
• Interleukin-2 immunotherapy followed by resection of residual renal cell carcinoma.

  1991cited by this paper
• Surveillance as a possible option for management of metastatic renal cell carcinoma.

  1989cited by this paper
• Long-term Survival and Late Recurrence

  1983cited by this paper
• Exstrophy of urinary bladder

  1974cited by this paper

• Clear Cell Renal Cell Carcinoma Metastatic to the Mandible: a Unique Case Report and Literature Review.

  2023cites this paper
• COMPLICATION AND OUTCOMES ASSOCIATED WITH SURGICAL MANAGEMENT OF RENAL CELL CARCINOMA: LITERATURE REVIEW.

  2017cites this paper
• Complications and Outcomes Associated With Surgical Management of Renal Cell Carcinoma Involving the Liver: A Matched Cohort Study.

  2017cites this paper
• Laparoscopic Cytoreductive Nephrectomy: A Three-Center Retrospective Analysis

  2010cites this paper
• Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review.

  2008cites this paper
• Prognostic factors for long-term survival in patients with thoracic metastatic disease: a 10-year experience.

  2007cites this paper
• Combination of surgery and immunotherapy in metastatic renal cell carcinoma

  2005cites this paper